Каталог · ЕАЭС
Клинические исследования и проекты
Calliditas Therapeutics AB · найдено 2
2 исследования
Завершено
Фаза III
Беларусь
НЕФЕКОН®
An Open-Label Extension (OLE) Study to Evaluate the Efficacy and Safety of Nefecon Treatment in Patients With IgA Nephropathy Who Have Completed Study Nef-301
Завершено
Фаза III
Беларусь
НЕФЕКОН®
A Randomized, Double-blind, Placebo Controlled Study to Evaluate Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy at Risk of Progressing to End-stage Renal Disease (NefIgArd)